ARTICLE | Distillery Therapeutics
Cancer
May 30, 2018 6:55 PM UTC
Mouse studies suggest inhibiting MAP3K7 could help treat metastatic triple-negative breast cancer (TNBC). In a xenograft mouse model of metastatic TNBC, cross-linked multilamellar liposomal vesicles l...
BCIQ Company Profiles
BCIQ Target Profiles